Next Generation Protein Therapeutics

Tid 28 September 2010 – 29 September 2010

Plats Sheraton Brussels Hotel Brussels, Belgium

Spotlight Presentation 29th September, 10.15 : Real Time Cell Surface Interaction Analysis Dr. Miriam Dwek , Senior Lecturer in Biochemistry, Department of Molecular & Applied Biosciences, University of Westminster will present drug conjugate data using the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bridging the gap between traditional biosensors and cell based assays. Attana will also be present in the exhibition area, giving conference participants the opportunity to see the Attana Cell 200 instrument firsthand. For 25% delegate discount click here: www.informaglobalevents.com/newsletter/index/id/293258/member// Event homepage: www.informaglobalevents.com/event/nextgen

Kategorier

  • biosensor
  • attana

Relaterat innehåll

Biosensor- Attana Cell 200, label free, real time kinetics on cells

Revolutionary Swedish invention can potentially improve drug development! Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.

PEGS 2010 with Attana!

We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!

Fight against cancer - Attana's collaborator interviewed

Attana's collaborator at Gothenburg University, Dr. Sture Lindegren, is interviewed about a possible new cure for ovarian cancers. Using the Attana Cell 200 instrument, Dr. Lindegren and his team are testing antibodies as carriers of radionuclide that target cancer cells directly instead of affecting the whole body as current cancer therapies do.

Biotech companies - Ways to work more efficiently

Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:
Seizing funding opportunities. Companies need to broaden the search for capital to include nontraditional (and non-dilutive) sourc

Universities and Innovation

We consider it strategically important to keep collaborating with our customers, university researchers in particular, to stay on top and keep getting inspired.

Attana- inspiring health

At Attana we aim at improving health in society by helping our customers in their scientific research, whether they are university researchers or pharmaceutical companies developing efficient treatment against severe diseases. However, another way to stay healthy is to eat wisely and exercise, and we Attanians exercise in abundance. For instance, several years in a row Attana has...

Relaterade event

Recombinant Antibodies: Covagen AG presents the Fynomer technology

Tid 14 Juni 2010 – 18 Juni 2010

Plats The Crowne Plaza Berlin City Centre, Germany

Evaluating Novel Technologies for Cell Based Screening

Tid 15 Juni 2010 – 16 Juni 2010

Plats Sheraton Philadelphia City Center - USA

Discovery 2010

Tid 19 September 2010 – 21 September 2010

Plats Red Rock Casino Resort Spa, Las Vegas, USA